𝔖 Bobbio Scriptorium
✦   LIBER   ✦

15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data

✍ Scribed by Baldassano, R.; Colletti, R.; Cucchiara, S.; Dubinsky, M.; Escher, J.; Faubion, W.; Fell, J.; Gold, B.; Griffiths, A.; Hyams, J.; Koletzko, S.; Kugathasan, S.; Markowitz, J.; Ruemmele, F.M.; Veereman, G.; Callegari, P.; Molenda, M.; Tang, K.L.; Wright, R.; Winter, H.


Book ID
122810954
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
70 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES